Jonathan Sheena - 26 Jan 2024 Form 4 Insider Report for Natera, Inc. (NTRA)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
30 Jan 2024, 21:05:22 UTC
Prior SEC filing
23 Jan 2024
Next SEC filing
08 Feb 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Tami Chen, Attorney-in-Fact

Key filing fact

Jonathan Sheena filed Form 4 for Natera, Inc. (NTRA) on 30 Jan 2024.

Key facts

  • This page summarizes Jonathan Sheena's Form 4 filing for Natera, Inc. (NTRA).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 30 Jan 2024, 21:05.

Change

  • Previous filing in this sequence was filed on 23 Jan 2024.
  • Current net transaction value: -$35,540.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NTRA transaction

Common Stock

Award

Transaction value
Shares
+9,405
Change %
+2%
Price
Shares after
479,131
Date
26 Jan 2024
Ownership
Direct
Footnotes
F1, F2
NTRA transaction

Common Stock

Sale

Transaction value
$35,540
Shares
-546
Change %
-0.11%
Price
$65.09
Shares after
478,585
Date
29 Jan 2024
Ownership
Direct
Footnotes
F3
NTRA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
21,155
Date
26 Jan 2024
Ownership
By Caraluna 1 Trust
Footnotes
F4
NTRA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
21,155
Date
26 Jan 2024
Ownership
By Caraluna 2 Trust
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person. The RSUs vest over four years. 25% of the RSUs vest on January 26, 2025 and the remaining RSUs vest in 12 equal quarterly installments thereafter.

Footnote F2

Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Footnote F3

The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and in compliance with Rule 10b5-1.

Footnote F4

Held for the benefit of the Reporting Person's minor children. The Reporting Person disclaims beneficial ownership over such securities.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .